Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
BiomX's Acne Vulgaris Treatment Fails To Top Vehicle Treatment Cohort
Tickers PHGE
Tags Phase 2 Trial Market News PHGE
From Benzinga
Vertex Unveils First Patient Results On Potential Diabetes Treatment
Tickers VRTX
Tags Briefs VRTX News
From Benzinga
Regenxbio Reveals Interim Data From Diabetic Retinopathy Gene Therapy Trial
Tickers RGNX
Tags News Benzinga Briefs
From Benzinga
Bristol Myers' TYK2 Inhibitor Disappoints In Mid-Stage Ulcerative Colitis Study
Tickers BMY
Tags Movers General ulcerative colitis
From Benzinga
Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program
Tickers DNLI SNY
Tags News Health Care Biotech
From Benzinga
Entera Bio's Formulated Human Parathyroid Hormone Shows Encouraging BMD Data
Tickers ENTX
Tags Penny Stocks General ENTX
From Benzinga
Vaxart Starts Recruitment In Mid-Stage COVID-19 Oral Vaccine Trial
Tickers VXRT
Tags VXRT COVID/19 Coronavirus Small Cap
From Benzinga
Takeda Discontinues Two Mid-Stage Narcolepsy Trials
Tickers TAK TKPHF
Tags TAK General Briefs
From Benzinga
Why Did Kaleido Shares Plunge 10% On Tuesday?
Tickers KLDO
Tags General Movers ulcerative colitis
From Benzinga
Gemini Axes Chief Scientific Officer, 20% Of Staff To Focus On Geographic Atrophy Candidate
Tickers GMTX
Tags Penny Stocks General Market News
From Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
Tickers ANVS
Tags General Parkinson’s Disease Biotech
From Benzinga
Why Did RedHill Biopharma Shares Jump 12% Monday?
Tickers RDHL
Tags RDHL COVID/19 Coronavirus Phase 3 Trial
From Benzinga
Enanta To Discontinue Internal Development Of NASH Candidates
Tickers ENTA
Tags Small Cap Market News Phase 2 Trial
From Benzinga
AnaptysBio Reveals Updated Imsidolimab Data In Severe Form Of Psoriasis
Tickers ANAB
Tags ANAB Market News Phase 2 Trial
From Benzinga
CTI BioPharma's COVID-19 Candidate Misses Primary Endpoint Mark In Phase 2 Trial
Tickers CTIC
Tags Health Care Biotech Benzinga
From Benzinga
Xenon Pharma Shares Jump After Epilepsy Treatment Phase 2 Data Meets Primary Endpoint
Tickers XENE
Tags Small Cap Health Care Biotech
From Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
Tickers JNJ
Tags REspiratory syncytial virus General Phase 2 Trial
From Benzinga
Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients
Tickers LLY
Tags LLY General ulcerative colitis
From Benzinga
Precigen Posts Additional Interim Data From Type 1 Diabetes Trial
Tickers PGEN PRVB
Tags Trading Ideas News Type I Diabetes
From Benzinga
BioNTech Starts Dosing In Mid-Stage Colorectal Cancer Immunotherapy Trial
Tickers BNTX RHHBF RHHBY RHHVF
Tags RHHBF General Movers
From Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
Tickers NERV
Tags Benzinga Biotech Health Care
From Benzinga
AIM ImmunoTech Recruits hVIVO For Ampligen Trial For Prophylaxis Use Against Respiratory Viruses
Tickers AIM
Tags General Penny Stocks AIM
From Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
Tickers REGN RHHBF RHHBY RHHVF
Tags Briefs News General
From Benzinga
Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate
Tickers EDIT
Tags Gene Editing Health Care Biotech
From Benzinga
Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
Tickers ADGI AZN AZNCF MRNA
Tags Benzinga Biotech Health Care
From Benzinga
Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial
Tickers GRAY REGN
Tags REGN Penny Stocks General
From Benzinga
Why Are I-Mab Shares Trading Higher On Tuesday?
Tickers IMAB MGNX MRK
Tags Health Care Benzinga Biotech
From Benzinga
Valneva, Pfizer Lyme Disease Vaccine Candidate Drops-Off After 18 Months
Tickers PFE VALN
Tags Briefs News Trading Ideas
From Benzinga
Ultragenyx Resumes Dosing Antisense Trial In Rare Neurogenetic Disorder
Tickers RARE
Tags Phase 1 Trial Angelman syndrome Biotech
From Benzinga
Pfizer Kick Starts Late-Stage Study For COVID-19 Oral Antiviral For Post-Exposure Prophylaxis
Tickers PFE
Tags Briefs News General
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.